In cross-sectional analyses, there are diverging results as AD patients exhibited either increased [17], similar [18], or decreased [19] serum and cerebrospinal fluid (CSF) levels of IGF-I compared with controls. The gene discussed is IGF1; the disease is Alzheimer disease.